Target intelligence / Profile preview

Kelch-like protein 13 (KLHL13)

Target
KLHL13
Molecular classification
Substrate adaptor protein, BTB-Kelch protein, Component of Cullin 3-based E3 ubiquitin ligase complex, Other (E3 ligase complex-associated protein)
01

Overview

Kelch-like protein 13 (KLHL13) is a substrate adaptor protein of the BTB-CUL3-RBX1 (BCR) E3 ubiquitin-protein ligase complex, necessary for proper mitotic progression and cytokinesis[2][3]. KLHL13 facilitates ubiquitination of specific substrate proteins, including Aurora kinase B (AURKB), thereby regulating chromosome segregation during mitosis[2]. This protein contains characteristic domains of the KLHL family: a BTB/POZ domain (protein binding and dimerization), a BACK domain (whose mutations are linked with disease), and five or six Kelch repeat motifs (involved in substrate recognition)[1]. KLHL family proteins play important roles in cellular protein degradation, cytoskeletal organization, and cellular morphology, and have been implicated in both hereditary diseases and cancer[1][4]. Mutations or dysfunction in KLHL13 or related proteins can perturb cell division and have been associated with neurological and oncological disorders such as Charcot-Marie-Tooth Disease and cancer[2]. Key notes: - No drugs are currently listed as direct KLHL13 antagonists/agonists. - KLHL13 is not a classical receptor, ion channel, or enzyme, but rather an E3 ligase complex adaptor, relevant for targeted protein degradation pathways[2][4]. - No known biomarkers or notable toxicity concerns specific to KLHL13 (apart from general disease association if mutated/disrupted). - The family and this gene are well-annotated, with no nomenclature errors.

Other names
Kelch like family member 13KLHL13BKLHD2KIAA1309FLJ10262BTB and kelch domain-containing protein 2kelch-like 13BTB and kelch domain containing 2
02

Mechanism of action

Functions as an adaptor protein with Cullin 3 for E3 ubiquitin ligase–directed substrate ubiquitination and degradation[2]

03

Biological functions

Ubiquitin-mediated protein degradationMitotic progression (chromosome segregation)Cytokinesis (final stage of cell division)Protein-protein interaction adapter
04

Disease associations

CancerCharcot-Marie-Tooth Disease (demyelinating, Type 1A)Other (potential roles in neurodevelopment, based on the KLHL family)

Beyond the preview

Go deeper on Kelch-like protein 13 (KLHL13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kelch-like protein 13 (KLHL13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call